BBVA
TRVI icon

Banco Bilbao Vizcaya Argentaria’s Trevi Therapeutics TRVI Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-70,000
Closed -$460K – 751
2020
Q2 		$460K Hold
70,000
– – 0.01% 568
2020
Q1 		$230K Buy
+70,000
New +$318K 0.01% 607

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's TRVI Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Trevi Therapeutics (TRVI) in Q3 2020, closing a stake of 70,000 shares — an estimated $460K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in TRVI in Q1 2020 and held it in 2 quarters. The position peaked at $460K in Q2 2020. 16 funds tracked by Wall St. Rank hold TRVI as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Trevi Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 70,000 Trevi Therapeutics shares in Q3 2020, an estimated $460K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Trevi Therapeutics in Q1 2020 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's Trevi Therapeutics position peaked at $460K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.